Minireviews
Copyright ©The Author(s) 2021.
World J Gastrointest Surg. Aug 27, 2021; 13(8): 796-805
Published online Aug 27, 2021. doi: 10.4240/wjgs.v13.i8.796
Table 1 Retrospective study published concentrating on surgical treatment for hepatocellular carcinoma patients with tumor thrombus in hepatic vein
Ref.
Treatment
Location of tumor thrombus
Patient number
OS
Prognostic factors
Chen et al[7], 2020Surgery, TACE, supportive treatmentHV, IVC43727.1 mo for type 1; 15 mo for type 2; 8 mo for type 3HVTT classification, treatment modality, coexistence of PVTT, total bilirubin, tumor diameter
Kokudo et al[4], 2017Surgical vs no surgicalHV, IVC651 vs 6154.47 yr vs 1.58 yr in pHVTT/mHVTT; 1.48 yr vs 0.84 yr in IVCTTIn pHVTT/mHVTT, PVTT, number of tumors, gastroesophageal varcices, poor cell differentiation
Li et al[14], 2015Hepatectomy en bloc vs hepatectomy combined with suction of tumor thrombusHV or portal vein28 vs 2814.3 mo vs 10.4 moPreoperative AFP level, treatment choice
Kokudo et al[6], 2014Hepatectomy combined with or without thrombectomyHV, IVC1745.27 yr for pHVTT; 3.95 yr for mHVTT; 1.39 yr for IVCTTLocation of tumor thrombus, R1/2 resection
Wang et al[12], 2013Hepatectomy and tumor thrombectomy vs TACE vs symptomatic treatmentIVC or RA 25 vs 20 vs 1119 mo vs 4 mo vs 5 moNumber of tumor nodules, treatment choice
Liu et al[5], 2012Hepatectomy and tumor thrombectomy vs TACE + chemotherapyRHV or IVC65 vs 5018 mo vs 7 moNot mentioned